The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sleep Disorder Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Sleep disorders result in a lack of deep and restorative sleep.
The global Sleep Disorder Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sleep Disorder Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Sleep Disorder Therapeutics market. Insomnia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Excessive Sleep segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sleep Disorder Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sleep Disorder Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sleep Disorder Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sleep Disorder Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sleep Disorder Therapeutics covered in this report include Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK and Neurim Pharmaceuticals, etc.
The global Sleep Disorder Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Global Sleep Disorder Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sleep Disorder Therapeutics market, Segment by Type:
Insomnia
Excessive Sleep
Disturbed Sleep
Global Sleep Disorder Therapeutics market, by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sleep Disorder Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Sleep disorders result in a lack of deep and restorative sleep.
The global Sleep Disorder Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sleep Disorder Therapeutics in various end use industries. The expanding demands from the Hospital Pharmacies, Online Pharmacies and Retail Pharmacies,, are propelling Sleep Disorder Therapeutics market. Insomnia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Excessive Sleep segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sleep Disorder Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sleep Disorder Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sleep Disorder Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sleep Disorder Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sleep Disorder Therapeutics covered in this report include Sanofi, Sunovion Pharmaceuticals, Takeda Pharmaceutical, Somaxon Pharmaceuticals, Vanda Pharmaceuticals, Eli Lilly, GSK and Neurim Pharmaceuticals, etc.
The global Sleep Disorder Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Global Sleep Disorder Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sleep Disorder Therapeutics market, Segment by Type:
Insomnia
Excessive Sleep
Disturbed Sleep
Global Sleep Disorder Therapeutics market, by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sleep Disorder Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sleep Disorder Therapeutics
1.1 Sleep Disorder Therapeutics Market Overview
1.1.1 Sleep Disorder Therapeutics Product Scope
1.1.2 Sleep Disorder Therapeutics Market Status and Outlook
1.2 Global Sleep Disorder Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sleep Disorder Therapeutics Market Size by Region (2018-2029)
1.4 Global Sleep Disorder Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Sleep Disorder Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sleep Disorder Therapeutics Market Size (2018-2029)
1.6.1 North America Sleep Disorder Therapeutics Market Size (2018-2029)
1.6.2 Europe Sleep Disorder Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Sleep Disorder Therapeutics Market Size (2018-2029)
1.6.4 Latin America Sleep Disorder Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Sleep Disorder Therapeutics Market Size (2018-2029)
2 Sleep Disorder Therapeutics Market by Type
2.1 Introduction
2.1.1 Insomnia
2.1.2 Excessive Sleep
2.1.3 Disturbed Sleep
2.2 Global Sleep Disorder Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sleep Disorder Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sleep Disorder Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sleep Disorder Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sleep Disorder Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sleep Disorder Therapeutics Revenue Breakdown by Type (2018-2029)
3 Sleep Disorder Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Online Pharmacies
3.1.3 Retail Pharmacies
3.2 Global Sleep Disorder Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sleep Disorder Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sleep Disorder Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sleep Disorder Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sleep Disorder Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sleep Disorder Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sleep Disorder Therapeutics Revenue Breakdown by Application (2018-2029)
4 Sleep Disorder Therapeutics Competition Analysis by Players
4.1 Global Sleep Disorder Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sleep Disorder Therapeutics as of 2022)
4.3 Date of Key Players Enter into Sleep Disorder Therapeutics Market
4.4 Global Top Players Sleep Disorder Therapeutics Headquarters and Area Served
4.5 Key Players Sleep Disorder Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Sleep Disorder Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Sleep Disorder Therapeutics Products, Services and Solutions
5.1.4 Sanofi Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Sunovion Pharmaceuticals
5.2.1 Sunovion Pharmaceuticals Profile
5.2.2 Sunovion Pharmaceuticals Main Business
5.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Products, Services and Solutions
5.2.4 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Sunovion Pharmaceuticals Recent Developments
5.3 Takeda Pharmaceutical
5.3.1 Takeda Pharmaceutical Profile
5.3.2 Takeda Pharmaceutical Main Business
5.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Products, Services and Solutions
5.3.4 Takeda Pharmaceutical Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Somaxon Pharmaceuticals Recent Developments
5.4 Somaxon Pharmaceuticals
5.4.1 Somaxon Pharmaceuticals Profile
5.4.2 Somaxon Pharmaceuticals Main Business
5.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Products, Services and Solutions
5.4.4 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Somaxon Pharmaceuticals Recent Developments
5.5 Vanda Pharmaceuticals
5.5.1 Vanda Pharmaceuticals Profile
5.5.2 Vanda Pharmaceuticals Main Business
5.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Products, Services and Solutions
5.5.4 Vanda Pharmaceuticals Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Vanda Pharmaceuticals Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Sleep Disorder Therapeutics Products, Services and Solutions
5.6.4 Eli Lilly Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 GSK
5.7.1 GSK Profile
5.7.2 GSK Main Business
5.7.3 GSK Sleep Disorder Therapeutics Products, Services and Solutions
5.7.4 GSK Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 GSK Recent Developments
5.8 Neurim Pharmaceuticals
5.8.1 Neurim Pharmaceuticals Profile
5.8.2 Neurim Pharmaceuticals Main Business
5.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Products, Services and Solutions
5.8.4 Neurim Pharmaceuticals Sleep Disorder Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Neurim Pharmaceuticals Recent Developments
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sleep Disorder Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sleep Disorder Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sleep Disorder Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sleep Disorder Therapeutics Market Dynamics
11.1 Sleep Disorder Therapeutics Industry Trends
11.2 Sleep Disorder Therapeutics Market Drivers
11.3 Sleep Disorder Therapeutics Market Challenges
11.4 Sleep Disorder Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
